Boqii Holding Ltd
BQAbout the company
Boqii Holding Limited operates as a pet-focused online retail business in the People's Republic of China. The company offers food, treats, shampoos, cages, toys, and apparel; OTC veterinary drugs, including dermatology drugs and worm medications; and other pet products to pet parents and small and medium pet businesses through self-operated online sales platforms, flagship stores on third-party e-commerce platforms, and an offline distribution network.
Investment snapshot
Positive
3
BUY / PASS
Neutral / negative
2 / 11
NEUTRAL / FAIL
Median fair value
—
No comparable estimates
Models with upside
0 / 17
Positive margin of safety
Strongest signal
9 of 12 pass — Buffett, Piotroski and Marks object
Key risk
All 10 investors flag BQ's cash flow
Framework analysis
| Verdict | Meaning |
|---|---|
| BUY | Positive purchase signal: the framework's buy requirements are met. |
| PASS | The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state. |
| NEUTRAL | Neither a positive nor negative conclusion. It does not mean to hold an existing position. |
| FAIL | The company does not clear the framework's requirements. |
| Ranked | Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL. |
Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.
| Metric | Graham Defensive Value | Buffett Quality Compounder | Lynch GARP | Greenblatt Magic Formula | Piotroski F-Score | Dreman Contrarian Value | Munger Quality Focus | Pabrai Dhandho Framework | Akre Three-Legged Stool | Marks Risk-Aware Value | Ackman Activist Value | Templeton Global Bargain Hunter | Sleep Scale Economies Shared | Asness Systematic Factors | Neff Low-P/E Total Return | Schloss Asset-Value Discipline | O'Shaughnessy Systematic Factor Composite |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verdict | FAIL | FAIL | FAIL | Not ranked | PASS | FAIL | PASS | FAIL | FAIL | FAIL | FAIL | NEUTRAL | FAIL | FAIL | FAIL | BUY | NEUTRAL |
| Score | |||||||||||||||||
| Analysis | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… | Checking access… |
| Intrinsic Value (annual) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Margin of Safety | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financial Basis | Annual history · FY 2025 Latest source filing: 2026-07-13 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-07-13 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-07-13 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-07-13 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-07-13 Score computed: 2026-11-14 | Annual history · FY 2025 · Market data at 2026-11-01 Latest source filing: 2026-07-13 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-07-13 Score computed: 2026-11-14 | Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-07-13 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-07-13 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-07-13 Score computed: 2026-11-14 | Annual history · FY 2025 · Market data at 2026-11-01 Latest source filing: 2026-07-13 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-07-13 Score computed: 2026-11-14 | Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-07-13 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-07-13 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-07-13 Score computed: 2026-11-14 | Annual history · FY 2025 Latest source filing: 2026-07-13 Score computed: 2026-11-14 | Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-07-13 Score computed: 2026-11-14 |
Where It Passes
- Debt & Leverage75% pass✓ 12✗ 3▾
9 of 12 pass — Buffett, Piotroski and Marks object
LT Debt vs Net Current AssetsLT Debt $2.3M vs NCA $19.4M✓GrahamLT Debt <= Net Current AssetsDebt/Equity & Interest CoverageD/E: 0.09, IC: -36.3x✗BuffettD/E < 0.5 AND Interest Coverage > 5xTotal Debt / Equity0.09✓Lynch< 0.33Cash - Long-term Debt$4.8M✓LynchPositive preferredLT Debt / Total Assets Change2.87% -> 6.62%✗PiotroskiDecreased YoYCurrent Assets / Current Liabilities3.25✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)Total Debt / Shareholders' Equity0.09✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00xDebt Levels0.09✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3Interest Coverage & Debt/EBITDAIC=-36.3x, D/EBITDA=N/A✗MarksInterest Coverage > 3x; Debt/EBITDA < 4xTotal Debt / Shareholders Equity0.09✓Ackman<= 1.0Negative debt-to-equity (higher means less debt)-0.0851; #1207/4210 (top 28.7%)✓AsnessTop 30% of eligible cross-section
Where It Falls Short
- Cash Flow0% pass✗ 12▾
All 10 investors flag BQ's cash flow
Free Cash Flow Proxy$-0.7M✗BuffettPositive and growingFCF Positive and Growing$-4.4M✗LynchPositive and growingOperating Cash Flow$-4.2M✗PiotroskiCFO > 0(CFO / Total Assets) vs ROACFO/Assets=-12.12%, ROA=-2.10%✗PiotroskiCFO/Assets > ROAPrice / (CFO / Shares)N/A (negative CFPS)✗Dreman< 8xP/E or FCF YieldFCF Yield=-138.4%✗PabraiP/E < 15 or FCF Yield > 10%FCF Positive0/8 years FCF positive✗MarksPositive FCF in majority of recent years(OCF - CapEx) / Market Cap-269.4%✗Ackman>= 4%Price / FCF per ShareN/A (negative FCF)✗Ackman<= 25Positive Operating Cash Flow frequency0/8 years positive✗SleepPositive OCF in >= 70% of available yearsOperating Cash Flow - Capital Expenditures$-4.4M✗Neff> $0 (app proxy for a strong fundamental case)(Operating cash flow - capex) / market capitalization-138.39%; #4131/4519 (top 91.4%)✗OshaughnessyTop 10% of eligible cross-section - Growth0% pass✓ 2✗ 11▾
No clean pass — all 8 investors flag at least one growth criterion
EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)✗Graham>= 33% growthBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passInventory Growth vs Revenue GrowthInv: -31.3% vs Rev: -5.8%✓LynchInventory growth < Revenue growthEPS Growth Direction$-4.19 (2018) -> $-0.21 (2025)✗DremanPositive over recent yearsEPS CAGR✗Dreman> 5% annualizedPositive Net Income Frequency0/8 years positive✗MarksPositive net income in >= 7 of last 10 years3yr Median Revenue Growth-34.2%✗Ackman>= 5%Positive EPS Growth Frequency3/5 years with positive EPS growth✓AckmanPositive EPS growth in >= 3 of last 5 years5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Revenue growth vs. gross and operating margin trendgross margin 19.8% -> 26.3%, operating margin -8.5% -> -7.1%✗SleepRevenue rising; gross margin flat or falling; operating margin holding5-year Revenue CAGR-16.9%✗SleepCAGR > 7%3-5 Year Diluted EPS CAGR✗Neff7%-20% annualized - Profitability6% pass✓ 6✗ 29▾
15 of 16 flag BQ's profitability — Graham, Buffett, Lynch +12 more
Positive EPS (10 years)0/9 years positive✗GrahamPositive EPS every year for 10 yearsEPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)✗Graham>= 33% growthNet Income Positive (10+ years)0/9 years positive✗BuffettPositive every year for 10+ yearsROE (up to 5-year arithmetic mean)-36.5%✗Buffett> 15% arithmetic mean (app rule)Operating Margin (10-yr trend)-7.1% (latest)✓BuffettStable or rising over 10 yearsFree Cash Flow Proxy$-0.7M✗BuffettPositive and growingEarnings Variance (10-yr CoV)N/A (negative mean EPS)✗BuffettCoV < 0.3Retained Earnings Effectiveness✗Buffett$1 retained -> > $1 market value createdBasic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)3-5 Year EPS CAGR✗Lynch15-30% (Fast Grower); > 0% to passROE-2.7%✗Lynch> 15%EBIT / Enterprise ValueN/A (EV <= 0)✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=N/A (EV <= 0), ROC=-34.8%✗GreenblattBoth EY > 10% and ROC > 25%Net Income / Total Assets-2.10%✗PiotroskiROA > 0ROA Change YoY-17.12% -> -2.10% (delta: +15.02%)✓PiotroskiCurrent ROA > Prior ROA(CFO / Total Assets) vs ROACFO/Assets=-12.12%, ROA=-2.10%✗PiotroskiCFO/Assets > ROAGross Margin Change YoY21.5% -> 26.3%✓PiotroskiImproved YoYPre-Tax Income / Revenue-0.2%✗Dreman>= 8%Net Income / Shareholders' Equity-2.7%✗Dreman> 12%Margin of SafetyP/B=0.1x✓PabraiP/B < 1.5 or P/E < 15Return on Equity-20.1% (3-yr avg)✗AkreROE > 20% (3-year avg)Discount to Intrinsic ValueN/A (negative normalized EPS)✗Marks>= 20% below intrinsic valuePositive Net Income Frequency0/8 years positive✗MarksPositive net income in >= 7 of last 10 yearsOperating Income / Revenue-7.1%✗Ackman>= 15%Net Income / Shareholders Equity-2.7%✗Ackman>= 15%5-Year EPS CAGR✗Templeton> 0% (5-year EPS CAGR)Operating Margin Trend-8.5% (2023) -> -7.1% (2025)✓TempletonNon-negative operating-margin trend over 3 yearsRevenue growth vs. gross and operating margin trendgross margin 19.8% -> 26.3%, operating margin -8.5% -> -7.1%✗SleepRevenue rising; gross margin flat or falling; operating margin holdingNet income / market capitalization-23.15%; #4643/6340 (top 73.2%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionGross profit / total assets+45.68%; #780/3702 (top 21.1%)✓AsnessTop 30% of eligible cross-sectionNet income / positive book equity-2.70%; #3087/5226 (top 59.1%)✗AsnessTop 30% of eligible cross-sectionNegative 5-year standard deviation of ROA-0.0615; #2844/5884 (top 48.3%)✗AsnessTop 30% of eligible cross-section3-5 Year Diluted EPS CAGR✗Neff7%-20% annualizedPositive Diluted-EPS Years0/8 years positive✗Schloss>= 70% positive over 5-10 observed years (app rule) - Valuation8% pass✓ 10✗ 18▾
12 of 13 flag BQ's valuation — Graham, Lynch, Greenblatt +9 more
Price / 3-yr avg EPS✗Graham<= 15xPrice-to-Book Ratio0.1x✓Graham<= 1.5xP/E x P/B✗Graham<= 22.5Basic earnings-growth PEG (dividends excluded)✗Lynch< 1.0 (ideally < 0.5)EBIT / Enterprise ValueN/A (EV <= 0)✗Greenblatt> 10%Earnings Yield + ROC AssessmentEY=N/A (EV <= 0), ROC=-34.8%✗GreenblattBoth EY > 10% and ROC > 25%Price / EPS✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)Price / (CFO / Shares)N/A (negative CFPS)✗Dreman< 8xPrice / Book Value per Share0.1x✓Dreman< 1.2x✓Templeton< 1.5x✓SchlossP/B <= 0.80x (app cutoff)Valuation ReasonablenessOE Yield=-43.9%✗MungerP/E < 25 or Owner Earnings Yield > 5%P/E or FCF YieldFCF Yield=-138.4%✗PabraiP/E < 15 or FCF Yield > 10%P/B or P/E vs. Historical AverageP/B=0.1x✓MarksP/E < 15 or P/B < 2.0Discount to Intrinsic ValueN/A (negative normalized EPS)✗Marks>= 20% below intrinsic valuePrice / FCF per ShareN/A (negative FCF)✗Ackman<= 25Price vs. Trailing Low100% of trailing low ($0.43)✓Templeton<= 120% of trailing low (certified split-adjusted live window)Net income / market capitalization-23.15%; #4643/6340 (top 73.2%)✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-sectionPositive book equity / market capitalization+8.5719; #203/6449 (top 3.1%)✓AsnessTop 30% of eligible cross-sectionPrice / Diluted EPS✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)(EPS CAGR % + Dividend Yield %) / P/E✗Neff> 0.7 (Neff's published traditional edge)Price / Tangible Book Value per Share0.06x✓SchlossP/TBV <= 1.00x (app cutoff)Book Value per Share Change+3718.7%✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)Revenue / market capitalization+19.1713; #217/5247 (top 4.1%)✓OshaughnessyTop 10% of eligible cross-section(Operating cash flow - capex) / market capitalization-138.39%; #4131/4519 (top 91.4%)✗OshaughnessyTop 10% of eligible cross-sectionTrailing six-month price return through the evaluation date-44.86%; #4978/6202 (top 80.3%)✗OshaughnessyTop 10% of eligible cross-section - Verdicts21% pass✓ 3✗ 11▾
Split decision: 11 FAIL · 2 PASS · 2 NEUTRAL · 1 BUY
Overall verdict✗GrahamFAIL (3/9)✗BuffettFAIL (1/9)✗LynchFAIL (3/7)•GreenblattNot ranked✓PiotroskiPASS (F-Score 4)✗DremanFAIL (3/11)✓MungerPASS (2/4)✗PabraiFAIL (1/3)✗AkreFAIL (2/6)✗MarksFAIL (1/5)✗AckmanFAIL (3/9)•TempletonNEUTRAL (5/8)✗SleepFAIL (1/6)✗AsnessFAIL (Rank #1426/2370 (Top 60.2%))✗NeffFAIL (0/6)✓SchlossBUY (5/7)•OshaughnessyNEUTRAL (Not ranked) - Efficiency25% pass✓ 3✗ 8▾
6 of 8 flag BQ's efficiency — Buffett, Greenblatt, Piotroski +3 more
Current Ratio3.25✓Graham>= 2.0ROIC (3-5 yr avg)-35.3%✗Buffett> 10%ROIC - WACC-45.3%✗BuffettPositive (WACC = 10%)EBIT / (NWC + Net Fixed Assets)-34.8%✗Greenblatt> 25%Current Ratio Change YoY4.85 -> 3.25✗PiotroskiIncreased YoYRevenue / Total Assets Change YoY1.48x -> 1.74x✓PiotroskiImproved YoYCurrent Assets / Current Liabilities3.25✓Dreman> 1.5Return on Invested Capital-11.6%✗Munger> 15%ROIC (high and growing)FY2023: ROIC=-20.3%; FY2024: ROIC=-23.6%; FY2025: ROIC=-11.6%✗AkreLatest 3 consecutive FYs: ROIC > 15% in eachReinvestment Rate x ROICN/A (non-positive net income)✗AkreReinvestment Rate * ROIC > 10%ROIC (5-year)0/5 years above 12% (latest -11.6%)✗SleepROIC > 12% in a majority of years
Business & financials
Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.
Company Profile
Financial Snapshot
Shareholder Return
Fiscal 2025
Share retirement not available for this company.
- Buybacks
- —
- Dividends
- —
Company Financials
Latest TTM and quarters alongside annual years
TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.
| Metric | FY 2025Sources
| FY 2024Sources
| FY 2023Sources
| FY 2022Sources
| FY 2021Sources
|
|---|---|---|---|---|---|
| Market Cap | $3.2Mcurrent | $715.6Mest. | $336.1Mest. | $4.2Best. | $9.9Best. |
| Revenue | $60.8M↓6% | $64.6M↓34% | $98.2M↓38% | $159.0M↓15% | $187.0M |
| Operating Income | -$4.3M↑47% | -$8.2M↑2% | -$8.3M↑45% | -$15.1M↑31% | -$21.8M |
| Net Income | -$734.7K↑90% | -$7.5M↑15% | -$8.8M↑41% | -$15.0M↑26% | -$20.2M |
| EPS (Diluted) | $-0.21↓452% | $-0.04↑56% | $-0.09↑59% | $-0.22↑27% | $-0.30 |
| Gross Margin | 26.3%↑22% | 21.5%↑8% | 19.8%↓7% | 21.4%↑5% | 20.5% |
| Operating Margin | -7.1%↑44% | -12.7%↓49% | -8.5%↑11% | -9.5%↑18% | -11.7% |
| ROE | -2.7%↑91% | -28.5%↑2% | -29.1%↑50% | -57.7%↑11% | -64.5% |
| Total Debt | $2.3M↑86% | $1.2M↓41% | $2.1M↓83% | $12.6M↓51% | $25.4M |
| Shareholders' Equity | $27.2M↑4% | $26.1M↓14% | $30.3M↑17% | $25.9M↓17% | $31.4M |
| Current Ratio | 3.25↓33% | 4.85↑25% | 3.86↑87% | 2.07↑13% | 1.83 |
| Debt / Equity | 0.09↑78% | 0.05↓31% | 0.07↓86% | 0.48↓40% | 0.81 |
| Operating Cash Flow | -$4.2M↑54% | -$9.2M↓162% | -$3.5M↑55% | -$7.9M↑66% | -$23.2M |
| Free Cash Flow | -$4.4M↑55% | -$9.7M↓169% | -$3.6M↑56% | -$8.1M↑66% | -$23.7M |
Score history
Historical Score Timeline
Industry peers
Industry Peers
Similar companies in Retail
BQ vs Peers — Financial Grading
| Company | Market Cap | Price | Revenue | Net Income | ROE | D/E | Op. Margin | Curr. Ratio | Graham | Buffett | Lynch | Greenblatt | Piotroski | Dreman |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COSTCO WHOLESALE CORP /NEWCOST | $490.2B | $1106.21 | $275.2B | $8.1B | 27.8% | 0.20 | 3.8% | 1.03 | 2/9 | 5/9 | 6/7 | 1/3 | F-Score 6 | 3/11 |
| HOME DEPOT, INC.HD | $347.9B | $348.69 | $164.7B | $14.2B | 110.5% | 4.00 | 12.7% | 1.06 | 3/9 | 5/9 | 3/7 | 1/3 | F-Score 4 | 3/11 |
| TJX COMPANIES INC /DE/TJX | $148.4B | $134.37 | $60.4B | $5.5B | 53.9% | 0.28 | — | 1.14 | 3/9 | 6/9 | 7/7 | 1/3 | F-Score 7 | 4/11 |
| FASTENAL COFAST | $63.3B | $55.19 | $8.2B | $1.3B | 31.9% | 0.03 | 20.2% | 4.85 | 4/9 | 7/9 | 5/7 | 1/3 | F-Score 7 | 5/11 |
| AUTOZONE INCAZO | $52.5B | $3259.70 | $18.9B | $2.5B | -73.2% | -2.61 | 19.1% | 0.88 | 3/9 | 6/9 | 2/7 | 1/3 | F-Score 6 | 4/11 |
| KROGER COKR | $41.8B | $70.80 | $147.6B | $1.0B | 17.1% | 2.68 | 1.3% | 0.80 | 3/9 | 4/9 | 3/7 | 0/3 | F-Score 7 | 3/11 |
| WILLIAMS SONOMA INCWSM | $29.9B | $254.05 | $7.8B | $1.1B | 52.3% | — | 18.1% | 1.39 | 3/9 | 6/9 | 3/7 | 1/3 | F-Score 5 | 3/11 |
| CASEYS GENERAL STORES INCCASY | $26.3B | $712.08 | $17.6B | $714.4M | 18.1% | 0.62 | — | 1.01 | 3/9 | 3/9 | 2/7 | 0/3 | F-Score 9 | 3/11 |